Target intelligence / Profile preview

Bone morphogenetic protein receptor complex (BMPR complex)

Target: BMPR complex
Molecular classification: Receptor, Serine/threonine kinase receptor, Transmembrane receptor, TGF-beta superfamily receptor

Overview

Bone morphogenetic protein receptors (BMPRs) are cell-surface transmembrane serine/threonine kinase receptors that mediate the effects of bone morphogenetic proteins (BMPs), key growth factors in the transforming growth factor-beta (TGF-β) superfamily. They function as heteromeric complexes composed of two classes: type I receptors (BMPR-IA/ALK3, BMPR-IB/ALK6, and sometimes ALK2) and type II receptors (BMPR-II, ActR-IIA, ActR-IIB). Upon BMP ligand binding, a tetrameric complex forms, type II receptor kinases transphosphorylate and activate type I kinases, which then phosphorylate intracellular SMAD1/5/8 proteins. These SMADs translocate to the nucleus, regulating transcription of target genes involved in development, bone formation, immune response, and cancer. BMPR complex dysregulation is implicated in diverse diseases, making the receptors both biomarkers and therapeutic targets.

Other names: Bone morphogenetic protein receptor (BMPR)BMPR-IA (ALK3)BMPR-IB (ALK6)BMPR-IIActivin receptor type IIA (ActR-IIA)Activin receptor type IIB (ActR-IIB)BMP receptor complexSerine/threonine kinase receptor complex

Mechanism of action

Inhibition or modulation of kinase activity to block SMAD1/5/8 phosphorylation and downstream transcriptional responses; Ligand traps or receptor antagonists to sequester ligands and inhibit receptor activation

Biological functions

Signal transductionRegulation of cell differentiationRegulation of cell proliferationEmbryogenesis and developmentOsteogenesis and bone homeostasisRegulation of immune responses

Disease associations

CancerBone diseases (e.g., fibrodysplasia ossificans progressiva)Pulmonary arterial hypertensionHereditary hemorrhagic telangiectasiaNeurodevelopmental and growth disordersInflammation

Safety considerations

Impaired bone formation and repairVascular effects (e.g., pulmonary hypertension risk with BMPR-II dysfunction)Potential impact on cancer progression, both stimulatory and inhibitory, depending on the contextOff-target effects due to the widespread role of the pathway in development and homeostasis

Interacting drugs

Kinase inhibitors targeting BMPRs (experimental and investigational)

2 more in the full profile.

Biomarkers

SMAD1/5/8 phosphorylation status as a readout of pathway activationBMPR gene mutation status (e.g., BMPR2 in pulmonary hypertension)Expression of BMP-responsive genes (e.g., ID1/ID2)

Beyond the preview

Go deeper on Bone morphogenetic protein receptor complex (BMPR complex).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bone morphogenetic protein receptor complex (BMPR complex).

Explore the full profile